Aug 7 |
Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?
|
Aug 1 |
Athira Pharma GAAP EPS of -$0.70 beats by $0.04
|
Aug 1 |
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
|
Jun 12 |
Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients
|
Jun 11 |
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)
|
Jun 3 |
We're A Little Worried About Athira Pharma's (NASDAQ:ATHA) Cash Burn Rate
|
May 15 |
Athira Pharma GAAP EPS of -$0.69
|
May 15 |
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
|
May 2 |
Athira Pharma to Participate in Upcoming May Conferences
|
Apr 23 |
One Athira Pharma Insider Raised Their Stake In The Previous Year
|